High-throughput Giardia lamblia viability assay using bioluminescent ATP content measurements

Antimicrobial Agents and Chemotherapy
Catherine Z ChenWei Zheng


The human pathogen Giardia lamblia is an anaerobic protozoan parasite that causes giardiasis, one of the most common diarrheal diseases worldwide. Although several drugs are available for the treatment of giardiasis, drug resistance has been reported and is likely to increase, and recurrent infections are common. The search for new drugs that can overcome the drug-resistant strains of Giardia is an unmet medical need. New drug screen methods can facilitate the drug discovery process and aid with the identification of new drug targets. Using a bioluminescent ATP content assay, we have developed a phenotypic drug screen method to identify compounds that act against the actively growing trophozoite stage of the parasite. This assay is homogeneous, robust, and suitable for high-throughput screening of large compound collections. A screen of 4,096 pharmacologically active small molecules and approved drugs revealed 43 compounds with selective anti-Giardia properties, including 32 previously reported and 11 novel anti-Giardia agents. The most potent novel compound was fumagillin, which showed 50% inhibitory concentrations of 10 nM against the WB isolate and 2 nM against the GS isolate.


Sep 1, 1992·Journal of Medical Microbiology·Roberto Cedillo-Rivera, O Muñoz
Jan 1, 1990·Pharmacology & Therapeutics·G S AhluwaliaD A Cooney
Jul 1, 1990·International Journal for Parasitology·Jacqueline A UpcroftP F Boreham
Dec 1, 1987·The Journal of Infectious Diseases·Theodore E NashM M Levine
Nov 1, 1985·The Journal of Antimicrobial Chemotherapy·P F BorehamR W Shepherd
Jun 1, 1972·The Journal of Antibiotics·S T Jaronski
Jan 1, 1983·Transactions of the Royal Society of Tropical Medicine and Hygiene·D B Keister
Nov 30, 1981·Biochimica Et Biophysica Acta·Y C LeeR H Himes
May 1, 1995·International Journal for Parasitology·M D FarbeyR C Thompson
Sep 1, 1994·Antimicrobial Agents and Chemotherapy·S K KatiyarT D Edlind
Aug 1, 1994·Infection and Immunity·L G ByrdTheodore E Nash
Aug 17, 1999·Annual Review of Nutrition·H W Baik, R M Russell
Dec 3, 1999·Antimicrobial Agents and Chemotherapy·M C Sousa, J Poiares-Da-Silva
Jun 6, 2000·Journal of Biomolecular Screening·J H ZhangK R Oldenburg
Nov 22, 2000·The Journal of Infectious Diseases·S M SingerTheodore E Nash
Jan 9, 2001·Clinical Microbiology Reviews·Peter Upcroft, Jacqueline A Upcroft
Mar 10, 2001·Clinical and Diagnostic Laboratory Immunology·M C SousaJ Poiares-Da-Silva
May 17, 2001·Antimicrobial Agents and Chemotherapy·Jacqueline A Upcroft, Peter Upcroft
Jul 4, 2001·Clinical Microbiology Reviews·Rodney D Adam
Jul 26, 2002·Molecular Microbiology·Theodore E Nash
Feb 15, 2003·Trends in Parasitology·André PaugamBertrand Friguet
Oct 31, 2003·Expert Opinion on Drug Safety·Janelle M WrightJacqueline A Upcroft
Dec 18, 2004·Advances in Parasitology·R C A Thompson, P T Monis
Dec 27, 2005·Antimicrobial Agents and Chemotherapy·Joachim MüllerAndrew Hemphill
Jul 18, 2006·Anti-cancer Agents in Medicinal Chemistry·Robert George Boyle, Stuart Travers
Jul 26, 2006·Proceedings of the National Academy of Sciences of the United States of America·James IngleseChristopher P Austin
Sep 14, 2006·Molecular Microbiology·Liudmila KulakovaTheodore E Nash
Oct 10, 2006·Nature Chemical Biology·Campbell McInnesDavid Glover
Aug 19, 2007·Expert Opinion on Pharmacotherapy·Angel A Escobedo, Sergio Cimerman
Sep 29, 2007·Science·Hilary G MorrisonMitchell L Sogin
Apr 10, 2008·The Annals of Pharmacotherapy·Greene Shepherd, Larissa I Velez
Apr 17, 2008·Cell Cycle·Kuzhuvelil B Harikumar, Bharat B Aggarwal
Apr 24, 2008·Metal-based Drugs·Stephen John Ralph
May 23, 2008·JALA : Journal of the Association for Laboratory Automation·Adam YasgarAnton Simeonov
Jul 2, 2008·Journal of Biomolecular Screening·Steven A TitusWei Zheng
Sep 18, 2008·Molecular and Biochemical Parasitology·Rubén Bonilla-SantiagoGiovanni Widmer
Feb 12, 2009·European Journal of Medicinal Chemistry·Emanuel Hernández-NúñezGabriel Navarrete-Vazquez
Sep 25, 2009·PloS One·Wendy A LeaRoderic G Eckenhoff
Jan 15, 2010·Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progrès Dans Les Recherches Sur Le Cancer·Hermann Einsele
May 12, 2010·International Journal of Antimicrobial Agents·Linda A DunnJacqueline A Upcroft


Feb 14, 2013·Antimicrobial Agents and Chemotherapy·Noa Tejman-YardenLars Eckmann
Nov 13, 2013·Antimicrobial Agents and Chemotherapy·Vijay BahadurBrajendra Kumar Singh
Feb 18, 2014·International Journal for Parasitology. Drugs and Drug Resistance·Surekha ShridharJosé A Fernández Robledo
Oct 23, 2014·PloS One·Yesmalie Alemán Resto, José A Fernández Robledo
Aug 7, 2018·PLoS Neglected Tropical Diseases·Kelly M HennesseyKayode K Ojo
Apr 28, 2017·Clinical Microbiology Reviews·Abebe Genetu BayihDylan R Pillai
Feb 22, 2014·The Journal of Biological Chemistry·Andrey GalkinOsnat Herzberg
Oct 31, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Seong-Min LeeDongyun Shin
Aug 23, 2011·Current Opinion in Infectious Diseases·Noa Tejman-Yarden, Lars Eckmann
Mar 21, 2020·PLoS Neglected Tropical Diseases·Gretchen EhrenkauferUpinder Singh
Aug 12, 2020·Antimicrobial Agents and Chemotherapy·Janak PadiaOsnat Herzberg
Mar 6, 2019·Nature Microbiology·Maya A Farha, Eric D Brown
Jul 12, 2017·Mediators of Inflammation·Juliana Alves Parente-RochaMaristela Pereira
Feb 5, 2020·The Journal of Antimicrobial Chemotherapy·Samantha A MichaelsKayode K Ojo
Dec 29, 2020·European Journal of Medicinal Chemistry·Jaime Pérez-VillanuevaOlivia Soria-Arteche
Feb 19, 2021·International Journal for Parasitology. Drugs and Drug Resistance·Alexander Y F LamSamantha J Emery-Corbin
Mar 18, 2021·European Journal of Pharmacology·Shalki ChoudharyOm Silakari
Sep 2, 2020·Journal of Medicinal Chemistry·Andrew RichesTina S Skinner-Adams

Related Concepts

Fumidil B
Adenosine Triphosphate, Chromium Ammonium Salt
Fatty Acids, Unsaturated
Phosphorescent Measurements
Chinese Hamster Ovary Cell

Related Feeds

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.


This feed focuses mechanisms underlying addiction and addictive behaviour including heroin and opium dependence, alcohol intoxication, gambling, and tobacco addiction.